Brian Gregory Pierce

USPTO Granted Patents = 9 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Marblehead, MA (US) (2016 - 2018)
Darnestown, MD (US) (2020)
Wayland, MA (US) (2014 - 2021)

Company Filing History:

University of Notre Dame Du Lac

patents

4. 2 out of 1,552

University of Massachusetts

patents

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11110158 - Prostate-associated antigens and vaccine-based immunotherapy regimens (2021-09-07),

2. 10526391 - Molecular constructs and uses thereof (2020-01-07),

3. 9987341 - PCSK9 vaccine (2018-06-05),

4. 9717758 - High-affinity DMF5 T cell receptor (TCR) variants (2017-08-01),

5. 9481875 - PCSK9 vaccine (2016-11-01),

6. 9468672 - Prostate-associated antigens and vaccine-based immunotherapy regimens (2016-10-18),

7. 9066898 - Prostate-associated antigens and vaccine-based immunotherapy regimens (2015-06-30),

8. 8895017 - HER-2 peptides and vaccines (2014-11-25),

9. 8889144 - PCSK9 vaccine (2014-11-18),

Title: Innovations and Contributions of Brian Gregory Pierce

Introduction

Brian Gregory Pierce is a notable inventor based in Wayland, MA (US), recognized for his significant contributions to the field of immunotherapy and molecular biology. With a total of 9 patents to his name, Pierce has made remarkable advancements in the development of therapeutic strategies for cancer and infectious diseases.

Latest Patents

Among his latest patents, Pierce has developed innovative solutions such as "Prostate-associated antigens and vaccine-based immunotherapy regimens." This patent includes isolated immunogenic PAA polypeptides, nucleic acid molecules encoding these polypeptides, and vaccine compositions that utilize them. Additionally, he has introduced methods for co-administering vaccines with immune-suppressive-cell inhibitors and immune-effector-cell enhancers. Another significant patent is focused on "Molecular constructs and uses thereof," which details constructs that enhance T-cell specificity and affinity for target antigens. These advancements aim to improve the efficacy of T-cell mediated therapies in treating various pathologies.

Career Highlights

Throughout his career, Brian Gregory Pierce has worked with prominent organizations, including Pfizer Corporation and Pfizer Vaccines, LLC. His experience in these companies has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Pierce has collaborated with esteemed colleagues such as James Richard Merson and Helen Kim Cho, further enhancing the impact of his work in the field of immunotherapy.

Conclusion

Brian Gregory Pierce's innovative patents and collaborations have significantly advanced the understanding and treatment of diseases through immunotherapy. His work continues to inspire future research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.